Description
Investigation of allelic polymorphism of two genetic markers associated with sensitivity to caffeine (ADORA2A (c.1083T>C)) and its metabolism (CYP1A2 (c.-163C>A)) to determine the physiological efficacy of caffeine use and drugs based on it.
Period of execution
Within 11 days. The specified time does not include the day of biomaterial collection
Biomaterial type